Julie Szeker - 12 Dec 2025 Form 4 Insider Report for Lumexa Imaging Holdings, Inc. (LMRI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Dec 2025, 17:49:11 UTC
Prior SEC filing
15 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Julie Szeker

Key filing fact

Julie Szeker filed Form 4 for Lumexa Imaging Holdings, Inc. (LMRI) on 16 Dec 2025.

Key facts

  • This page summarizes Julie Szeker's Form 4 filing for Lumexa Imaging Holdings, Inc. (LMRI).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 16 Dec 2025, 17:49.

Change

  • Previous filing in this sequence was filed on 15 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002101138 Primary reporting owner

Szeker Julie

Relationship
Chief Legal Officer & Corp Sec
Address
4200 SIX FORKS ROAD, SUITE 1000, RALEIGH
Signature
/s/ Julie Szeker
Signature date
16 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMRI transaction

Common Stock

Options Exercise

Transaction value
Shares
+66,182
Change %
Price
Shares after
66,182
Date
12 Dec 2025
Ownership
Direct
Footnotes
F1, F2, F3
LMRI transaction

Common Stock

Award

Transaction value
$0
Shares
+81,081
Change %
+123%
Price
$0.000000
Shares after
147,263
Date
12 Dec 2025
Ownership
Direct
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMRI transaction Derivative

Incentive Units of Holdings LLC

Options Exercise

Transaction value
$0
Shares
-1,250,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
66,182
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2]

Footnote F2

[continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO.

Footnote F3

Includes 11,876 shares of Common Stock that will vest upon the attainment of a prescribed stock price target of $24.97 per share, which target is measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period, subject to the Reporting Person's continued service with the Issuer.

Footnote F4

Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in full on December 12, 2026, subject to the Reporting Person's continued service with the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .